The Beljanski Foundation, in partnership with Natural Source, is organizing a symposium for healthcare professionals only on Saturday, December 3, 2016 in New York City.
The highlight of the symposium will be the past, present and future advancements in research on a natural and effective approach to cancer, based upon the innovative work of Pasteur Institute researcher, Dr. Mirko Beljanski. Dr. Beljanski’s holistically focused research on botanical extracts, revolutionary at the time, has gained tremendous momentum and further acceptance in recent years. His botanical extracts stand apart due to his rigorous research with the highest quality, non-toxic natural ingredients. Mirko Beljanski (1923-1998), biochemist and biologist, spent his professional career at the Pasteur Institute in Paris, studying the causes and mechanisms of gene activation, DNA duplication, and cell division in both normal and malignant states.
Over the course of many years, Dr. Beljanski studied the toxicological and pharmacological properties of botanical extracts from Pao pereira and Rauwolfia vomitoria. He analyzed their mode of action in vitro and in vivo and found that both extracts destroyed cancer cells, but did not cause any toxicity in healthy cells. In addition, Dr. Beljanski was one of the first biologists to study small RNA fragments, which play an important role in the generation of specific cell populations. Some RNA fragments stimulate the formation of white blood cells and platelets.
Dr. Beljanski discovered that they not only help maintain normal white blood cell and platelet levels that fall to dangerously low levels due to radiation therapy and chemotherapy, but they also preserve normal ratios among the various kinds of white blood cells, including those that fight infections. Attendees will hear results of clinical trials as well as past research and current programs being conducted around the world on select botanical products. Presenters will include Michael Schachter, MD, head of the Schachter Center for Complementary Medicine, Qi Chen, PhD, researcher at Kansas University Medical Center, Jillian Capodice, LAC, from Mt. Sinai Health System, and James Grutsch, PhD, who oversaw the clinical trial on RNA fragments at the Cancer Treatment Centers of America. These scientists will discuss the results of their research and their practical experience using the natural approach developed by Dr. Beljanski.
Please share with us the contact information of your colleagues who might be interested in attending the event and learning more about an alternative and natural approach to health.
SEATS ARE LIMITED, SAVE YOUR SPOT TODAY!